New clinical trials in Germany: 2,190 since Nov 2024

Name: New clinical trials in Germany
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New clinical trials with a site in Germany: 2,190 rows for $101.90, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 62 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/country/germany, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

2,190 clinical studies with a site in Germany were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 1,196 have an industry sponsor and 1,568 are recruiting or about to. The newest, NCT07926932, was posted on November 9, 2026: Whole-Body Electromyostimulation and Speed Climbing (University of Erlangen-Nürnberg Medical School).

The request: Every new clinical trial with a site in Germany, with the sponsor, phase, conditions and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

2,190New trials
1,196Industry sponsored
1,568Recruiting or not yet
November 9, 2026Latest posted

Newest trials

The newest 100 of 2,190, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 9, 2026	NCT07926932	Whole-Body Electromyostimulation and Speed Climbing	University of Erlangen-Nürnberg Medical School	Not applicable	Not yet recruiting	Athletic Performance	18	Germany	clinicaltrials.gov
November 9, 2026	NCT07926321	A Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard Treatment	Boehringer Ingelheim	Phase 2	Not yet recruiting	Idiopathic Pulmonary Fibrosis	70	Belgium, Finland, Germany, Japan, Mexico, South Korea, Spain, United States	clinicaltrials.gov
November 9, 2026	NCT07926152	Exercise and Protein to Reduce Muscle Loss During GLP-1-Based Treatment in Type 2 Diabetes	German Diabetes Center	Not applicable	Not yet recruiting	Type 2 Diabetes (T2DM), Obesity & Overweight, Sarcopenia	94	Germany	clinicaltrials.gov
November 9, 2026	NCT07924943	Transarterial Chemoembolization (TACE) and Stereotactic Body Radiation (SBRT) in Patients With Hepatocellular Carcinoma (HCC) Prior to...	AIO-Studien-gGmbH	Not applicable	Recruiting	HCC - Hepatocellular Carcinoma	44	Germany	clinicaltrials.gov
November 9, 2026	NCT07924371	AI-Based Tools for Stroke Diagnosis, Treatment and Outcome Prediction: a Multicentre Prospective Observational Study	Hospital Universitari Vall d'Hebron Research Institute	Observational	Recruiting	Stroke, Ischemic Stroke, Intracerebral Hemorrhage, Transient Ischemic Attack, Atrial Fibrillation	10,000	Belgium, Germany, Italy, Netherlands, Spain, Switzerland	clinicaltrials.gov
November 6, 2026	NCT07921121	Assessment of Communication Interventions on Vaccination Knowledge and Acceptance	Charite University, Berlin, Germany	Not applicable	Recruiting	Vaccination Knowledge and Acceptance, Informed Vaccine-decision Making	1,524	Germany	clinicaltrials.gov
November 5, 2026	NCT07919405	A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and...	Novo Nordisk A/S	Phase 3	Not yet recruiting	Hypertension, Obesity	1,408	Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Denmark, Germany...	clinicaltrials.gov
November 5, 2026	NCT07918586	Localized Aeroallergen Exposure in Atopic Dermatitis	Fraunhofer-Institute of Toxicology and Experimental Medicine	Not applicable	Not yet recruiting	Atopic Dermatitis	15	Germany	clinicaltrials.gov
November 5, 2026	NCT07917780	A Prospective, Open-label, Randomized, Multicenter Phase-III Trial to Evaluate the Efficacy of Pirtobrutinib and Epcoritamab Compared With...	German CLL Study Group	Phase 2	Recruiting	Richter Transformation	116	Australia, Austria, Denmark, Germany, Ireland	clinicaltrials.gov
November 4, 2026	NCT07915219	A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)	Boehringer Ingelheim	Phase 3	Not yet recruiting	Bronchiectasis	1,500	Argentina, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czechia...	clinicaltrials.gov
November 3, 2026	NCT07913412	High-precision Radiosurgery Followed by Minimally Invasive Surgical Approach in Patients With High-prominence Uveal Melanoma: Modern...	University Hospital, Essen	Observational	Recruiting	Uveal Melanoma, High-risk Uveal Melanoma, Prominent Uveal Melanoma	250	Germany	clinicaltrials.gov
November 2, 2026	NCT07910370	Structured Treatment and Resource Efficiency Assessment With Lean Six Sigma Integration for Pulmonary Vein Isolation	St. Josefs-Hospital Wiesbaden GmbH	Not applicable	Recruiting	Atrial Fibrillation (AF)	94	Germany	clinicaltrials.gov
November 2, 2026	NCT07909382	Multi-biomarkers in DEE	Istituto Giannina Gaslini	Observational	Recruiting	Developmental and Epileptic Encephalopathies (DEE)	200	Belgium, Denmark, France, Germany, Israel, Italy, Netherlands, Spain	clinicaltrials.gov
October 30, 2026	NCT07908173	Magnetic Field Maps With NV Application Kit MCG	Bosch Quantum Sensing GmbH	Observational	Recruiting	Technical Feasibility and Performance of the Sensor System, Healthy Adult, Healthy Adult Participants	12	Germany	clinicaltrials.gov
October 30, 2026	NCT07908108	Cross-cultural Adaptation and Validation of the Localised Scleroderma Quality of Life Instrument (LoSQI) in Juvenile Localised Scleroderma...	Istituto Giannina Gaslini	Observational	Active not recruiting	Scleroderma	272	Argentina, Brazil, China, Croatia, Denmark, Egypt, Germany, Greece, India...	clinicaltrials.gov
October 30, 2026	NCT07908004	A Study to Test How Well Different Doses of BI 3821001 Are Tolerated by Healthy People	Boehringer Ingelheim	Phase 1	Not yet recruiting	Healthy	40	Germany	clinicaltrials.gov
October 30, 2026	NCT07906314	Post-Market Registry Study for Vibrant Hearing Solutions	MED-EL Elektromedizinische Geräte GmbH	Observational	Enrolling by invitation	Conductive Hearing Loss, Mixed Hearing Loss, Sensorineural Hearing Loss, Single Sided Deafness	50	Germany	clinicaltrials.gov
October 29, 2026	NCT07904546	ADBest TREAT Registry	Universitätsklinikum Hamburg-Eppendorf	Observational	Recruiting	Atopic Dermatitis	5,000	Germany	clinicaltrials.gov
October 29, 2026	NCT07903532	Multicenter Study for External Validation of the TB-NET Score	Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz	Observational	Recruiting	Tumor Burden, Neuroendocrine (NE) Tumors	400	Brazil, France, Germany, Italy, Poland, Spain, Sweden, Switzerland, United...	clinicaltrials.gov
October 28, 2026	NCT07902414	Mi2000 TICI Follow-up	MED-EL Elektromedizinische Geräte GmbH	Observational	Not yet recruiting	Hearing Loss, Binaural, Cochlear Implantation	36	Austria, Belgium, Germany, Poland	clinicaltrials.gov
October 28, 2026	NCT07901907	Monitoring and Early Detection of Treatable Inherited RETinal Disease in Children and Adolescents	University College, London	Observational	Recruiting	Inherited Retinal Degeneration Associated With RPGR Mutations, Inherited Retinal Degeneration Associated With Biallelic...	4,887	Germany, United Kingdom, United States	clinicaltrials.gov
October 28, 2026	NCT07900672	Register for Medical Data, Functional Scales, and Care Outcomes in ALS, SMA, and Other Motor System Disorders	Ambulanzpartner Soziotechnologie APST GmbH	Observational	Recruiting	ALS (Amyotrophic Lateral Sclerosis), SMA - Spinal Muscular Atrophy, Spinal Cord Diseases, Central Nervous System...	2,000	Germany	clinicaltrials.gov
October 28, 2026	NCT07900633	A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk	Eli Lilly and Company	Phase 3	Not yet recruiting	Obesity, Overweight, Cardiovascular Diseases, Diabetes Mellitus, Type 2	3,000	Argentina, Australia, Brazil, Canada, China, Czechia, France, Germany, Hungary...	clinicaltrials.gov
October 27, 2026	NCT07898800	Safety, Tolerability And Pharmacodynamics of DM-101PX in Birch Pollen Allergy	Desentum Oy	Phase 1	Recruiting	Birch Pollen Allergy	40	Germany	clinicaltrials.gov
October 27, 2026	NCT07898774	A Study to Assess the Efficacy and Safety of Pegcetacoplan for the Prevention of Recurrent C3G or Primary IC-MPGN in Kidney Transplant...	Swedish Orphan Biovitrum	Phase 3	Recruiting	C3 Glomerulopathy (C3G), Primary Immune-Complex Membranoproliferative Glomerulonephritis (IC-MPGN), Recurrent...	30	Brazil, Canada, Finland, France, Germany, Italy, Saudi Arabia, Spain...	clinicaltrials.gov
October 27, 2026	NCT07898098	Early Rehabilitation After Transfemoral Amputation in Moderately Active Patients Using the Avior Knee	Median	Not applicable	Enrolling by invitation	Transfemoral Amputees	33	Germany	clinicaltrials.gov
October 27, 2026	NCT07897968	GD2IL18CART Combined With Bevacizumab for Relapsed and Refractory GD2-positive Solid Tumors	Universität Münster	Phase 1	Not yet recruiting	Neuroblastoma (NBL), Ewing Sarcoma, Osteosarcoma	30	Germany	clinicaltrials.gov
October 27, 2026	NCT07897929	Exercise and Fall Prevention for Fracture Reduction	Wolfgang Kemmler, PhD	Not applicable	Not yet recruiting	Osteopenia, Osteoporosis, High Fall Risk	72	Germany	clinicaltrials.gov
October 27, 2026	NCT07897760	Evaluating the Effects of the EXOPULSE Suit on Mobility, Walking Ability, and Balance in People With Multiple Sclerosis	Otto Bock Healthcare Products GmbH	Not applicable	Not yet recruiting	Multiple Sclerosis	100	Germany, United States	clinicaltrials.gov
October 27, 2026	NCT07897110	AI-generated Treatment Recommendations in Precision Oncology	Charite University, Berlin, Germany	Observational	Recruiting	Cancer	191	Germany	clinicaltrials.gov
October 26, 2026	NCT07896109	A Research Study to Check the Safety of NNC9836-0001 When Given to Healthy Participants and Participants With Type 2 Diabetes	Novo Nordisk A/S	Phase 1	Not yet recruiting	Diabetes Mellitus, Type 2	121	Germany	clinicaltrials.gov
October 22, 2026	NCT07889739	Sensation Seeking and TMS Response in TRD	Technical University of Munich	Observational	Recruiting	MDD, Severe Depression, Major Depressive Episode	100	Germany	clinicaltrials.gov
October 22, 2026	NCT07889388	RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes Study	Bionime Corporation	Not applicable	Recruiting	Diabetes Mellitus, Type 1 Diabetes, Diabetes Mellitus, Type 2, Diabetes, Gestational	104	Germany	clinicaltrials.gov
October 22, 2026	NCT07888738	Evaluation of Safety, Performance and Usability of the TR Band DISTAL Device for Hemostasis Following Distal Radial Access in Coronary...	Terumo Europe N.V.	Observational	Not yet recruiting	Hemostasis, Distal Radial Artery Access (dTRA)	320	Austria, Belgium, Germany, Italy	clinicaltrials.gov
October 22, 2026	NCT07888647	IDH1-vac in Patients With Newly Diagnosed IDH1R132H-positive High-grade Astrocytomas	German Cancer Research Center	Phase 2	Not yet recruiting	Astrocytoma, IDH-Mutant, Grade 3, Astrocytoma, IDH-Mutant, Grade 4	216	Germany	clinicaltrials.gov
October 22, 2026	NCT07888582	Effectiveness and Safety of the RIGHTEST™ CGM System for Blood Glucose Management in Persons With Diabetes Mellitus	Bionime Corporation	Not applicable	Completed	Diabetes Mellitus	50	Germany	clinicaltrials.gov
October 22, 2026	NCT07888322	Assessment of Intelligent Algorithms for Detection, Diagnosis and Risk Stratification of Tumors of the Kidney and Prostate	Aristotle University Of Thessaloniki	Observational	Not yet recruiting	Kidney Cancers, Prostate Cancer	50	Germany, Greece, Italy, Spain	clinicaltrials.gov
October 22, 2026	NCT07888257	LIfestyle MEtabotype Study B (LIME-B)	German Institute of Human Nutrition	Not applicable	Recruiting	Nutritional and Metabolic Diseases, Prediabetes, Type 2 Diabetes	300	Germany	clinicaltrials.gov
October 21, 2026	NCT07886502	Upper Airway Morphology and Physiology During Graded Positive Pressure and Nasal High Flow: An MRI Study	Klinikum Dortmund Wirbelsäulenchirurgie	Observational	Not yet recruiting	Chronic Obstructive Pulmonary Disease (COPD)	20	Germany	clinicaltrials.gov
October 21, 2026	NCT07885189	Long-Term Cognitive Recovery After Arteria Cerebri Media Ischemia: A Digital Assessment Using the TuCAN-App	University Hospital Tuebingen	Observational	Recruiting	Cognitive Recovery After Stroke, Cognitive Outcome After Stroke	50	Germany	clinicaltrials.gov
October 21, 2026	NCT07885176	Deep Repetitive Transcranial Magnetic Stimulation in the Treatment of Tinnitus	University of Regensburg	Not applicable	Recruiting	Tinnitus, Tinnitus, Bilateral	60	Germany	clinicaltrials.gov
October 21, 2026	NCT07884994	HUGO-SLEEVE: Evaluating the Feasibility of Robotic Sleeve Gastrectomy With a New Platform	Universitätsklinikum Hamburg-Eppendorf	Not applicable	Recruiting	Obesity (BMI > 35), Obesity (BMI > 35) and Diabetes Mellitus, Obesity (BMI > 35) and Dyslipemia, Obesity (BMI > 35) and...	50	Germany	clinicaltrials.gov
October 20, 2026	NCT07883954	Development and Multi-Centre Validation of a Novel Non-Invasive Melanoma Molecular Diagnostic Test	Mitra Bio	Observational	Recruiting	Melanoma	2,000	Belgium, Germany, Spain, United Kingdom	clinicaltrials.gov
October 20, 2026	NCT07883460	Improving Combined PET/CT and MRI of the Breast Using Dedicated Breast Positioning and Image Registration	Universität Münster	Not applicable	Not yet recruiting	Breast Cancer, Breast - Female	20	Germany	clinicaltrials.gov
October 20, 2026	NCT07882797	Multimodal Characterization of Movement Trajectories in Chronic Inflammatory Demyelinating Polyneuropathy	Heinrich-Heine University, Duesseldorf	Observational	Recruiting	CIDP - Chronic Inflammatory Demyelinating Polyneuropathy	50	Germany	clinicaltrials.gov
October 20, 2026	NCT07882290	Study With Batten-1 (Miglustat Liquid Formulation) to Treat Ceroid Lipofuscinosis Neuronal 3 (CLN3) Disease	Beyond Batten Disease Foundation	Phase 3	Not yet recruiting	CLN3	27	Denmark, France, Germany, Italy, Netherlands, Sweden, United Kingdom, United...	clinicaltrials.gov
October 20, 2026	NCT07882225	Microneedle-based ISF Sampling Technique	Ascilion AB	Not applicable	Not yet recruiting	No Condition, Healthy Individuals	110	Germany	clinicaltrials.gov
October 19, 2026	NCT07881679	Breast MRI for Early Detection of Breast Cancer in Thuringia	Jena University Hospital	Observational	Active not recruiting	Breast Cancer	750	Germany	clinicaltrials.gov
October 19, 2026	NCT07881458	A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes	Eli Lilly and Company	Phase 3	Recruiting	Obesity, Overweight, Diabetes Mellitus, Type 2	1,000	Brazil, China, Germany, Japan, Puerto Rico, Romania, South Korea, Spain...	clinicaltrials.gov
October 19, 2026	NCT07881432	A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes	Eli Lilly and Company	Phase 3	Not yet recruiting	Obesity	2,115	Argentina, China, Germany, India, Japan, Puerto Rico, South Korea, United...	clinicaltrials.gov
October 19, 2026	NCT07881185	Artificial Intelligence for Brain MRI Analysis in Epilepsy	Istituto Giannina Gaslini	Observational	Recruiting	Epilepsies	2,000	Australia, Belgium, Brazil, Canada, China, Germany, Italy, Mexico, South...	clinicaltrials.gov
October 19, 2026	NCT07879781	Respiratory Viral Infections Following Oktoberfest Attendance	LMU Klinikum	Observational	Recruiting	Respiratory Viral Infections Associated With Oktoberfest Attendance	4,000	Germany	clinicaltrials.gov
October 16, 2026	NCT07877298	Within-Session Repeatability of EUS-Guided Portal Pressure Gradient Measurement	University Hospital Muenster	Observational	Not yet recruiting	Portal Hypertension, Chronic Liver Disease, Liver Cirrhosis	150	Belgium, Canada, Germany, Italy	clinicaltrials.gov
October 16, 2026	NCT07877272	Endohepatology-Based Reclassification of Treatment Indication in High-Risk MASLD	University Hospital Muenster	Observational	Recruiting	Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis, Liver...	500	Germany	clinicaltrials.gov
October 15, 2026	NCT07876089	Validation and Comparative Multi-Omics Benchmarking of Fluid-Derived Volatilomics Biomarkers for the Prevention and Early Detection of...	University Hospital, Aachen	Observational	Active not recruiting	Schizophrenia / Schizoaffective Disorder	3,692	Germany	clinicaltrials.gov
October 14, 2026	NCT07874139	Prospective Study on Antimicrobial RESIstance in Chronic Pulmonary DiseasE	Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico	Observational	Recruiting	Chronic Lung Diseases	683	Albania, Australia, Belgium, Brazil, Canada, China, Croatia, Czechia, Denmark...	clinicaltrials.gov
October 14, 2026	NCT07873931	A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases	Bristol-Myers Squibb	Phase 1	Not yet recruiting	Systemic Lupus Erythematosus, Sjögren's Disease, Rheumatoid Arthritis, Idiopathic Inflammatory Myopathies, Systemic...	60	Belgium, France, Germany, Netherlands, Poland, United States	clinicaltrials.gov
October 14, 2026	NCT07872774	Decompressive Craniectomy After Aneurysmal Subarachnoid Hemorrhage (DECIDE-SAH)	University Hospital, Essen	Observational	Not yet recruiting	Aneurysmal Subarachnoid Hemorrhage	10,000	Germany	clinicaltrials.gov
October 13, 2026	NCT07872020	SYMmetric Valve fraME Expansion To Reduce hYpoattenuated Leaflet Thickening After Balloon-expandable TAVI: the SYMMETRY Trial	Erasmus Medical Center	Not applicable	Recruiting	Aortic Valve Stenosis and/or Insufficiency, Hypoattenuated Leaflet Thickening, Valve Expansion, Transcatheter Aortic...	422	Germany, Netherlands	clinicaltrials.gov
October 13, 2026	NCT07871214	A Study to Assess The Safety and Tolerability of Pumitamig-Based Therapy Administered Before Surgery in Participants With Early-Stage...	Bristol-Myers Squibb	Phase 2	Not yet recruiting	Early-Stage Non-Small Cell Lung Cancer	80	Australia, Canada, China, France, Germany, Italy, Japan, Poland, Romania, South...	clinicaltrials.gov
October 13, 2026	NCT07870577	Peripheral Neuropathy in Patients Receiving Enfortumab Vedotin and Pembrolizumab as Perioperative Systemic Therapy for Urothelial Carcinoma	Comprehensive Cancer Center Munich (CCCM)	Observational	Recruiting	Urothelial Cancer, MIBC	79	Germany	clinicaltrials.gov
October 9, 2026	NCT07868653	Exercise Intervention to Support Recovery After Allogeneic Stem Cell Transplantation in Adults With Myeloid Blood Disorders	Universität Duisburg-Essen	Not applicable	Not yet recruiting	Myeloid Malignancies	80	Germany	clinicaltrials.gov
October 9, 2026	NCT07868601	LIfestyle MEtabotype Study A	German Institute of Human Nutrition	Observational	Recruiting	Nutritional and Metabolic Diseases, Prediabetes, Type 2 Diabetes	300	Germany	clinicaltrials.gov
October 9, 2026	NCT07867886	An Optimization Study Evaluating Safety and Efficacy of the Y-90 Glioblastoma (GBM) Device in Patients With Recurrent GBM	Boston Scientific Corporation	Not applicable	Not yet recruiting	Recurrent Glioblastoma	30	France, Germany, Netherlands, Spain	clinicaltrials.gov
October 6, 2026	NCT07861100	A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular...	Novo Nordisk A/S	Phase 3	Not yet recruiting	Cardiovascular Risk, Obesity	8,500	Argentina, Australia, Brazil, Bulgaria, Canada, China, Czechia, Denmark...	clinicaltrials.gov
October 6, 2026	NCT07860762	Augmenting Clinical Workflow With a Structured Chatbot for Patient History Collection and Diagnostic Support	Massachusetts General Hospital	Observational	Not yet recruiting	Medical History Taking, Artificial Intelligence in Clinical Workflow, Outpatient Clinical Encounter	100	Germany	clinicaltrials.gov
October 6, 2026	NCT07860047	Multi-peptide Vaccination and Bispecific PSMAxCD3 Antibody Treatment in Patients With Prostate Cancer	University Hospital Tuebingen	Phase 2	Recruiting	Prostate Cancer	84	Germany	clinicaltrials.gov
October 6, 2026	NCT07859852	Evaluation of Diagnostic Accuracy and Clinical Performance of the UllCORE Bloodstream Infection (BSI) Test	Deepull Diagnostics S.L.	Observational	Recruiting	Blood Stream Infection, Blood Stream Infections, Sepsis, Fungemia, Bacteremia	1,500	France, Germany, Italy, Spain, United States	clinicaltrials.gov
October 5, 2026	NCT07859501	System Accuracy of the Blood Glucose Monitor for Personal Use Aria	Institut fur Diabetes Karlsburg GmbH	Observational	Completed	Diabetes	105	Germany	clinicaltrials.gov
October 5, 2026	NCT07858799	Early Feasibility Study of the Edwards APTURE Transcatheter Shunt System	Edwards Lifesciences	Not applicable	Recruiting	Heart Failure	15	Germany	clinicaltrials.gov
October 5, 2026	NCT07858123	Safety and Efficacy Comparison Between CHF5993 100/6 12.5µg pMDI to Seretide Evohaler 125/25µg pMDI in Adolescent Subjects With Asthma	Chiesi Farmaceutici S.p.A.	Phase 3	Not yet recruiting	Asthma	700	Germany, Italy, Spain	clinicaltrials.gov
October 5, 2026	NCT07857993	DETECTRA: Remote Monitoring to Detect Rheumatoid Arthritis Flares and Treatment Response	Centre Hospitalier Universitaire Vaudois	Not applicable	Not yet recruiting	Rheumatic Disorder, Rheumatoid Arthritis (RA)	320	Austria, Germany	clinicaltrials.gov
October 5, 2026	NCT07857460	German Hypoparathyroidism Registry	University Hospital Augsburg	Observational	Recruiting	Hypoparathyroidism, Pseudohypoparathyroidism	150	Germany	clinicaltrials.gov
October 5, 2026	NCT07857421	AI-Based Wearable Monitoring (Glandy HYPER) for Antithyroid Drug Dose Adjustment in Graves' Disease	THYROSCOPE INC.	Not applicable	Not yet recruiting	Hyperthyroidism, Graves Disease, Thyrotoxicosis	30	Germany	clinicaltrials.gov
October 5, 2026	NCT07857044	Left-atrial Fibrosis in Persistent Atrial Fibrillation and Its Comorbidities	Christina Berr. MD	Observational	Recruiting	Atrial Fibrillation, Sleep Apnea, Primary Aldosteronism	200	Germany	clinicaltrials.gov
October 2, 2026	NCT07855926	Perioperative Systemic Therapies in Muscle-Invasive Bladder Cancer (GUARDIANS)	LMU Klinikum	Observational	Recruiting	Urothelial Carcinoma of the Bladder, Muscle Invasive Bladder Cancer (MIBC)	500	Germany	clinicaltrials.gov
October 2, 2026	NCT07854431	CHECK-NIRS2D-Study	Heinrich-Heine University, Duesseldorf	Observational	Recruiting	NIRS, Tissue Oxygenation, Microvascular Perfusion, Vascular Occlusion Test, Ischemia-reperfusion, Healty Volunteers...	20	Germany	clinicaltrials.gov
October 1, 2026	NCT07851987	Pediatric Rhabdomyolysis in the Pediatric Intensive Care Unit: A Retrospective Cohort Study	Hannover Medical School	Observational	Completed	Rhabdomyolysis	55	Germany	clinicaltrials.gov
October 1, 2026	NCT07851493	Exercise Phenotyping Prior to Chemotherapy in Newly Diagnosed Multiple Myeloma (MM-Exercise)	Technical University of Munich	Observational	Recruiting	Exercise Behavior, Multiple Myeloma	80	Germany	clinicaltrials.gov
October 1, 2026	NCT07851025	Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced...	AstraZeneca	Phase 3	Recruiting	Epithelial Ovarian Cancer	950	Argentina, Australia, Brazil, Bulgaria, Canada, Chile, China, Colombia...	clinicaltrials.gov
September 30, 2026	NCT07850635	A Study of Mirdametinib in Infants and Toddlers With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas	SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany	Phase 1	Not yet recruiting	Neurofibromatosis Type 1-Associated Plexiform Neurofibromas	6	Germany	clinicaltrials.gov
September 30, 2026	NCT07850206	NutrImmune: Precision Nutrition to Improve Immunity in Individuals With Obesity	Institut National de la Santé Et de la Recherche Médicale, France	Not applicable	Not yet recruiting	Obesity (BMI>30), Immune Abnormalities, Low-grade Inflammation	168	France, Germany, Netherlands	clinicaltrials.gov
September 30, 2026	NCT07850063	ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and...	Boehringer Ingelheim	Phase 3	Not yet recruiting	Obesity, Metabolic Dysfunction-associated Steatotic Liver Disease	600	China, Germany, Spain, United Kingdom, United States	clinicaltrials.gov
September 30, 2026	NCT07849894	A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of UCB0159 in Participants With Mild to Moderate Psoriasis, Single...	UCB Biopharma SRL	Phase 1	Completed	Mild to Moderate Psoriasis, Healthy Volunteers	54	Germany, United Kingdom	clinicaltrials.gov
September 30, 2026	NCT07848295	A Study to Assess the Safety and Tolerability of BMS-986527 in Participants With Clear Cell Renal Cell Carcinoma (ccRCC)	Juno Therapeutics, Inc., a Bristol-Myers Squibb Company	Phase 1	Not yet recruiting	Clear Cell Renal Cell Carcinoma (ccRCC)	112	Belgium, France, Germany, Italy, Netherlands, Spain, United States	clinicaltrials.gov
September 29, 2026	NCT07845630	A Study in Healthy People to Compare How 2 Different Formulations of Vicadrostat / Empagliflozin Tablets Are Taken up in the Body	Boehringer Ingelheim	Phase 1	Recruiting	Healthy	36	Germany	clinicaltrials.gov
September 28, 2026	NCT07844798	TORCH - Transdiagnostic Observation of Risk Factors, Craving and Health Behaviours in Psychiatric Patients	Jacobs University Bremen gGmbH	Observational	Not yet recruiting	Psychiatric Disorders	250	Germany	clinicaltrials.gov
September 28, 2026	NCT07844057	First-line Treatment in Locally Advanced or Metastastic Small Bowel Adenocarcinoma	Annika Kurreck	Phase 2	Not yet recruiting	Small-bowel Adenocarcinoma, Metastatic Disease, Chemotherapy Effect	86	Germany	clinicaltrials.gov
September 28, 2026	NCT07843940	A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35)	Boehringer Ingelheim	Phase 1/2	Recruiting	Extensive-stage Small Cell Lung Carcinoma, Advanced Small Cell Lung Cancer	55	Australia, Belgium, China, France, Germany, Japan, Netherlands, Poland, Spain...	clinicaltrials.gov
September 28, 2026	NCT07843927	Dehydroepiandrosterone (DHEA) as Augmentation of Standard Antidepressants in Treatment-resistant Depression.	Charite University, Berlin, Germany	Phase 3	Recruiting	Treatment Resistant Depression (TRD)	320	Germany	clinicaltrials.gov
September 25, 2026	NCT07842874	A Comparison of Left Bundle Branch Optimized Cardiac Resynchronization Therapy vs Left Bundle Branch Area Pacing Alone	PD Dr. Guram Imnadze	Not applicable	Not yet recruiting	Heart Failure, Left Bundle Branch Area Pacing, Cardiac Resynchronization Therapy, Conduction System Pacing	124	Germany	clinicaltrials.gov
September 25, 2026	NCT07840612	A Study to Assess the Effects of Probenecid on the Pharmacokinetics of Mirdametinib and Its Metabolites in Healthy Participants	Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany	Phase 1	Recruiting	Healthy	17	Germany	clinicaltrials.gov
September 25, 2026	NCT07840456	Safety and Efficacy of Ruxolitinib in Patients With HNSCC and High NLR Treated With Pembrolizumab - The Phase 2 InflammaSTOP Trial	University Hospital, Basel, Switzerland	Phase 2	Not yet recruiting	Carcinoma, Squamous Cell of Head and Neck HNSCC	66	Germany, Switzerland	clinicaltrials.gov
September 25, 2026	NCT07840287	A Long-Term Extension (LTE) Study Of Enpatoran In Cutaneous Manifestations Of Lupus With Or Without Systemic Disease [Elowen-LTE]	EMD Serono Research & Development Institute, Inc.	Phase 3	Not yet recruiting	Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE)	404	Germany, United States	clinicaltrials.gov
September 24, 2026	NCT07840196	NG004 in Incomplete Spinal Cord Injury Patients	NovaGo Therapeutics AG	Phase 1	Recruiting	Acute Spinal Cord Injury (SCI), Spinal Cord Diseases, Spinal Cord Injuries, Trauma Nervous System	120	Germany, Switzerland	clinicaltrials.gov
September 24, 2026	NCT07839819	Study of PM54 in Combination With Cytotoxic and Targeted Agents in Adult Participants With Advanced Malignancies	PharmaMar	Phase 1/2	Not yet recruiting	Advanced Solid Tumor	231	France, Germany, Portugal, United States	clinicaltrials.gov
September 21, 2026	NCT07830732	A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A	Novo Nordisk A/S	Phase 3	Recruiting	Haemophilia A	84	Argentina, Australia, Brazil, Canada, Denmark, France, Germany, Greece, India...	clinicaltrials.gov
September 21, 2026	NCT07830719	Dose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerability in Adults With Stable Coronary Artery Disease and Elevated hsCRP	Novartis Pharmaceuticals	Phase 2	Recruiting	Coronary Artery Disease	180	Australia, Germany, Japan, United Kingdom, United States	clinicaltrials.gov
September 21, 2026	NCT07830615	Bicycle Ergometry and Peripheral Hemodynamics: a Pilot Study	ARCIM Institute Academic Research in Complementary and Integrative Medicine	Not applicable	Completed	Effects of Standardized Physical Exercise on a Bicycle Ergometer on the Perfusion Index (PI) and Other Cardiovascular...	12	Germany	clinicaltrials.gov
September 18, 2026	NCT07827924	Designing a Large Language Model Architecture for Shared Decision Making and Informed Intentions	Harding Center for Risk Literacy	Not applicable	Recruiting	Shared Decision Making, Health Literacy, Patient Participation, Artificial Intelligence	330	Germany	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
AstraZeneca	81	October 1, 2026
Boehringer Ingelheim	63	November 9, 2026
Charite University, Berlin, Germany	51	November 6, 2026
Eli Lilly and Company	51	October 28, 2026
Novartis Pharmaceuticals	48	September 21, 2026
Universitätsklinikum Hamburg-Eppendorf	45	October 29, 2026
Novo Nordisk A/S	39	November 5, 2026
Sanofi	36	July 7, 2026
Merck Sharp & Dohme LLC	35	May 29, 2026
Technical University of Munich	33	October 22, 2026
University Hospital Tuebingen	32	October 21, 2026
Hoffmann-La Roche	32	September 17, 2026
Bristol-Myers Squibb	30	October 14, 2026
Pfizer	26	May 19, 2026
Heinrich-Heine University, Duesseldorf	25	October 20, 2026
Janssen Research & Development, LLC	25	June 24, 2026
University Hospital, Bonn	24	September 17, 2026
University of Erlangen-Nürnberg Medical School	23	November 9, 2026
AbbVie	19	July 27, 2026
Bayer	19	July 23, 2026

Conditions

Condition group	New trials	Latest
Obesity	82	November 9, 2026
Overweight	60	November 9, 2026
Carcinoma, Non-Small-Cell Lung	53	October 13, 2026
Heart Failure	53	October 5, 2026
Breast Neoplasms	49	October 20, 2026
Diabetes Mellitus, Type 2	44	November 9, 2026
Prostatic Neoplasms	40	October 22, 2026
Neoplasms	37	October 29, 2026
Atrial Fibrillation	36	November 9, 2026
Depression	31	October 22, 2026
Colorectal Neoplasms	31	September 10, 2026
Lung Neoplasms	29	August 26, 2026
Multiple Myeloma	28	October 1, 2026
Neoplasm Metastasis	26	September 28, 2026
Anxiety Disorders	26	July 23, 2026
Colitis, Ulcerative	26	June 17, 2026
Motor Activity	25	October 27, 2026
Diabetes Mellitus	25	October 22, 2026
Pulmonary Disease, Chronic Obstructive	25	October 21, 2026
Arthritis, Rheumatoid	25	October 14, 2026
Stroke	23	November 9, 2026
Cardiovascular Diseases	23	October 28, 2026
Diabetes Mellitus, Type 1	23	October 22, 2026
Dermatitis, Atopic	22	November 5, 2026
Hidradenitis Suppurativa	20	June 24, 2026

By phase

Phase	New trials	Latest
Observational	621	November 9, 2026
Not applicable	554	November 9, 2026
Phase 3	464	November 5, 2026
Phase 2	252	November 9, 2026
Phase 1	153	October 30, 2026
Phase 1/2	73	September 28, 2026
Phase 2/3	38	April 29, 2026
Phase 4	31	August 26, 2026
Early phase 1	4	July 23, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.